Spring direct naar de hoofdnavigatie of de inhoud
‘In the end it's all about the value that the patent adds to the product.’
Mark Einerhand

Mark Einerhand

  • Life Sciences
  • European and Dutch Patent Attorney
  • Partner

Mark Einerhand has been active in the patent world since 1998, when he made the switch from a biotech startup to V.O.

Mark’s career started in science. After his studies of molecular biology at the University of Amsterdam, he took his PhD in medical science inLeiden, in 1992. He was a visiting scientist at Cornell University in New York and the MRC at Mill Hill in London.

Continue reading

His particular expertise lies in the field of medical (bio)technology, diagnostics and medicines. Because of his background at Introgene/Crucell, Mark has a special affinity with Life Science startups. He has a wide experience in patent cases before the court in The Hague.

Working experience

  • Patent Attorney, V.O. (1998-present)
  • IntroGene (now Crucell), Rijswijk (1995)
  • Post-Doc at Leiden University (1993)
  • Medical Research Council, Mill Hill, London (1992)
  • Visiting Scientist, Cornell University New York (1992)

Education

  • PhD in Medicine, Leiden University (1992)
  • MSc in Biochemistry, University of Amsterdam (1987), Major in Molecular Oncology, Dutch Cancer Institute

Publications

  • Co-author of article ‘The patentability of stem cells in Europe’, IAM Life Sciences 2015.
    Einerhand, M.P.W. (2011): Advance offering of generics found to infringe. Managing Intellectual Property: Vol 205: page: 87.
  • Einerhand M.P.W. (2010): A contribution to: Legal and intellectual property issues associated with stem cells. In: Stem Cells; scientific facts and fiction, (C. Mummery; I. Wilnut, A van de Stolpe and
    B.A.J. Roelen), Academic Press: Elsevier.
  • Einerhand M.P.W. and van Melle, J (2004): Patenting of inventions in the field of bio-informatics.
    In: The new avenues in Bioinformatics, (Seckbach, J and Rubin, E eds), Kluwer Academic Publishers, the Netherlands.
  • Principle inventor on Patents and Patent Applications: Einerhand, M.P.W. and Valerio (1997). WO 98/32870: US 6,232,105: A conditional replication and expression system. Einerhand, M.P.W. and Valerio (1997). WO 99/32647: Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into chromosomal DNA of target cells in gene therapy. Einerhand, M.P.W. and Valerio (1996). WO98/24924: NZ 336185:
  • Transduction of primate hemopoietic repopulating stem cells. Einerhand, M.P.W. and Valerio (1995). WO 97/20943: US 6,140,103: Regulated protein expression in stably transfected mammalian cells. Einerhand, M.P.W. (1992) Gene transfer into hemopoietic stem cells: prospects for human gene therapy. University of Leiden.

Professional & Community Activities

  • Member of the Steering Committee World IP Forum 2015
    Former member of the European Qualifying Examination committee III

Languages

  • English
  • Dutch
  • German

Also see these experts

Andreas Keymer

Andreas Keymer

  • European and German Patent Attorney, European Patent Litigator
  • Associate
Tamara Elmore

Tamara Elmore

  • European and Dutch Patent Attorney, European Patent Litigator
  • United States Patent Agent
  • Partner
More experts

News

Enforcement of intellectual property rights

You have invested considerable time, energy and expense in developing and protecting an invention, design, trademark or logo. At some point you discover that a third party enters the market with a method, product, design or trademark that appears to infringe on your intellectual property (IP) rights. The question is what action you can take.Continue reading

Relaxation of rules for transfer of right of priority

The right of priority is the basis of international patent protection, allowing the applicant to continue the original patent application abroad within one year while maintaining the original filing date. In recent years, an increasing number of patents have been revoked in opposition proceedings at the European Patent Office (EPO) due to an invalid transfer […]Continue reading

Are experimental data needed for your patent application?

‘Should we carry out more experiments to substantiate the concept of our invention? Or will this take too much time, and will it give the competition an opportunity to file their application earlier?’ These are questions that many innovative companies face each time when a new patentable idea is conceived.Continue reading

Events

Jobfair Vlaamse Technische Kring (VTK) 2024

Brabanthal, Brabantlaan, Leuven, België

The VTK Jobfair will take place on Thurday 14 March 2024. The Jobfair falls during an interesting time for students to find out what the business market has to offer. It is the ideal opportunity for students to get in touch with companies through VTK.

Continue reading

Graduate Jobfair Ghent 2024

Flanders Expo, Maaltekouter, Ghent, Belgium

De Graduate Jobfair Ghent 2024 is organized by the Ghent University Association.
(Almost) graduated and looking for your first challenging job? Or, looking for further education after your bachelor (BA) or master (MA)? Get to know the current job market and a wide range of further study opportunities.

Continue reading

JCI Flemish-Brabant Young Entrepreneur of the Year 2024

De Hoorn, Sluisstraat, Leuven, Belgium

JCI Flemish-Brabant Young Entrepreneur of the Year. Our society is constantly changing. And let that be precisely the goal of Junior Chamber International ("JCI"): to bring about positive changes in our society.

Continue reading